| Aldose Reductase: A cause and a potential target for the treatment of diabetic complications S Thakur, SK Gupta, V Ali, P Singh, M Verma Archives of Pharmacal Research 44, 655-667, 2021 | 88 | 2021 |
| Drug-metabolizing enzymes: role in drug resistance in cancer G Kaur, SK Gupta, P Singh, V Ali, V Kumar, M Verma Clinical and Translational Oncology 22, 1667-1680, 2020 | 84 | 2020 |
| Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy SK Gupta, P Singh, V Ali, M Verma Oncology reviews 14 (2), 2020 | 46 | 2020 |
| Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review V Kumar, P Singh, SK Gupta, V Ali, M Verma Molecular and Cellular Biochemistry 477 (4), 1261-1279, 2022 | 28 | 2022 |
| Alterations in cellular metabolisms after Imatinib therapy: a review V Kumar, P Singh, SK Gupta, V Ali, Jyotirmayee, M Verma Medical Oncology 39 (7), 95, 2022 | 6 | 2022 |
| Downregulation of Bcr-Abl oncogene in Chronic Myeloid Leukemia by microRNAs P Singh, SK Gupta, V Ali, M Verma Asian Pac J Health Sci 5 (4), 65-84, 2018 | 4 | 2018 |
| Therapeutic approaches to enhance the BCR-ABL tyrosine kinase inhibitors efficacy in chronic myeloid leukemia SK Gupta, P Singh, V Ali, M Verma Asian Pac J Health Sci 6, 58-69, 2019 | 3 | 2019 |
| Small in Size, Big in Impact: Marine Microbes, a Boon for Biotherapeutics P Singh, KC Saini, V Ali, SK Gupta, M Verma Marine Niche: Applications in Pharmaceutical Sciences: Translational …, 2020 | 2 | 2020 |
| miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming P Singh, S Kumar Gupta, V Ali, R Chhabra, M Verma Indian Journal of Biochemistry and Biophysics (IJBB) 60 (3), 167-176, 2023 | 1 | 2023 |
| Metabolic flux analysis in plant metabolic network V Ali, P Singh, SK Gupta, VY Muley, M Verma | | 2019 |
| Non-alcoholic fatty liver disease progression and current research S Narayan, SK Gupta, P Singh, V Ali, M Verma | | |
